(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.95%) $81.15
(-2.16%) $1.948
(-0.26%) $2 296.90
(0.25%) $26.72
(-0.36%) $944.80
(0.13%) $0.938
(0.27%) $11.13
(0.16%) $0.802
(0.00%) $93.45
Live Chart Being Loaded With Signals
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies...
Stats | |
---|---|
Šios dienos apimtis | 40 400.00 |
Vidutinė apimtis | 61 533.00 |
Rinkos kapitalizacija | 39.14B |
EPS | ¥0 ( 2024-04-12 ) |
Kita pelno data | ( ¥0 ) 2024-07-11 |
Last Dividend | ¥30.00 ( 2023-05-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.04 |
ATR14 | ¥1.923 (0.08%) |
Tūris Koreliacija
Daito Pharmaceutical Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Daito Pharmaceutical Koreliacija - Valiuta/Žaliavos
Daito Pharmaceutical Finansinės ataskaitos
Annual | 2022 |
Pajamos: | ¥45.10B |
Bruto pelnas: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
FY | 2022 |
Pajamos: | ¥45.10B |
Bruto pelnas: | ¥10.33B (22.91 %) |
EPS: | ¥227.64 |
FY | 2022 |
Pajamos: | ¥43.46B |
Bruto pelnas: | ¥11.46B (26.36 %) |
EPS: | ¥335.41 |
FY | 2021 |
Pajamos: | ¥48.71B |
Bruto pelnas: | ¥10.79B (22.16 %) |
EPS: | ¥311.02 |
Financial Reports:
No articles found.
Daito Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥30.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥4.55 | 2010-05-27 |
Last Dividend | ¥30.00 | 2023-05-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | ¥396.45 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.49 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.80 | |
Div. Directional Score | 7.50 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9067.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7952.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7184.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6428.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5408.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4430.T | Ex Dividend Knight | 2024-05-30 | Annually | 0 | 0.00% | |
3608.T | Ex Dividend Junior | 2024-02-28 | Annually | 0 | 0.00% | |
2813.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
1433.T | Ex Dividend Junior | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
9735.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0726 | 1.500 | 8.55 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0424 | 1.200 | 8.59 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0639 | 1.500 | -0.402 | -0.602 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.29 | 0.800 | 3.53 | 2.82 | [1 - 3] |
quickRatioTTM | 1.083 | 0.800 | 8.33 | 6.67 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0944 | -1.500 | 8.43 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 182.83 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.141 | -1.500 | 9.44 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.214 | 1.000 | 9.77 | 9.77 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0930 | 1.000 | -0.139 | -0.139 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.744 | 1.000 | 6.98 | 6.98 | [0.2 - 2] |
assetTurnoverTTM | 0.584 | 0.800 | 9.44 | 7.55 | [0.5 - 2] |
Total Score | 11.20 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.04 | 1.000 | 8.89 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0639 | 2.50 | -0.258 | -0.602 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.28 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 346.01 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.475 | 1.500 | -6.50 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.50 | 0 | [0.1 - 0.5] |
Total Score | 3.80 |
Daito Pharmaceutical
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.